Publications by authors named "Daniel El Fassi"

Claim this Profile
P
Prevalence of tick-borne neoehrlichia mikurensis in individuals undergoing B-cell depleting therapy in Denmark: A prospective cohort study 2023-2024.
Helene Mens, Rosa Gynthersen, Jeppe Romme Christensen, Morten Blinkenberg, Finn Sellebjerg, Daniel El Fassi

Int J Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment.
Morten M Johansen, Daniel El Fassi, Christoffer T H Nielsen, Sophine B Krintel, Niels Graudal

Rheumatology (Oxford)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DAHEAN: A Danish nationwide study ensuring quality assurance through real-world data for suspected hereditary anemia patients.
Andreas Glenthøj, Andreas Ørslev Rasmussen, Selma Kofoed Bendtsen, Henrik Hasle, Marianne Hoffmann, Daniel El Fassi

Orphanet J Rare Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibody therapies.
Luiz Henrique de Assis, Daniel El Fassi, Martin Hutchings

Hematology Am Soc Hematol Educ Program· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoehrlichia mikurensis-An emerging opportunistic tick-borne infection in immunosuppressed patients.
Rosa M M Gynthersen, Christen Rune Stensvold, Signe Ledou Nielsen, Holger Jon Møller, Henrik Vedel Nielsen, Daniel El Fassi

J Intern Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The multidisciplinary approach to eosinophilia.
Gunhild Nynke Thomsen, Mette Niemann Christoffersen, Hanne Merete Lindegaard, Jesper Rømhild Davidsen, Gitte Nyvang Hartmeyer, Daniel El Fassi

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial.
Jacob Handlos Grauslund, Morten Orebo Holmström, Evelina Martinenaite, Thomas Landkildehus Lisle, Hannah Jorinde Glöckner, Daniel El Fassi

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial.
Camilla Fuchs Andersen, Massar Omar, Andreas Glenthøj, Daniel El Fassi, Holger J Møller

Eur J Heart Fail· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Rosa Maja Møhring Gynthersen, Frederikke Christina Knudtzen, Anders Porskrog, Karen Krogfelt, Mette Frimodt Hansen, Daniel El Fassi

Ugeskr Laeger· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies.
Sunil Kumar Saini, Staffan Holmberg-Thydén, Anne-Mette Bjerregaard, Ashwin Unnikrishnan, Simon Dorfmüller, Daniel El Fassi

Leukemia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression.
Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J W Peeters, Daniel El Fassi

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of next-generation sequencing in routine diagnostics and management of patients with cytopenia.
Marie Fredslund Breinholt, Kåre Nielsen, Lone Schejbel, Daniel El Fassi, Claudia Schöllkopf

Int J Lab Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression.
Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Aneta Radziwon-Balicka, Daniel El Fassi

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.
Trine Alma Knudsen, Vibe Skov, Kristen Stevenson, Lillian Werner, William Duke, Daniel El Fassi

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.
Staffan Holmberg-Thydén, Inge Høgh Dufva, Anne Ortved Gang, Marie Fredslund Breinholt, Lone Schejbel, Daniel El Fassi

Cancer Immunol Immunother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Elevated blood cell counts and vascular disease with the myeloproliferative neoplasms as model diseases].
Hans Carl Hasselbalch, Trine Alma Knudsen, Anders Lindholm Sørensen, Sarah Friis Christensen, Morten Kranker Larsen, Daniel El Fassi

Ugeskr Laeger· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias.
Annelies J van Vuren, Alaa Sharfo, Simon T Grootendorst, Stephanie van Straaten, Arjen M Punt, Daniel El Fassi

Hemasphere· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A user's guide to multicolor flow cytometry panels for comprehensive immune profiling.
Staffan Holmberg-Thyden, Kirsten Grønbæk, Anne Ortved Gang, Daniel El Fassi, Sine Reker Hadrup

Anal Biochem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2.
Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Daniel El Fassi

Blood Adv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Variant Detection in Clinical Myeloid NGS Testing by Supplementing a Commercial Myeloid NGS Assay with Custom or Extended Data Filtering and Accessory Fragment Analysis.
Lone Schejbel, Guy Wayne Novotny, Marie Fredslund Breinholt, Daniel El Fassi, Claudia Schöllkopf

Mol Diagn Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypercalcemia After Cosmetic Oil Injections: Unraveling Etiology, Pathogenesis, and Severity.
Ebbe Eldrup, Simone Theilade, Mette Lorenzen, Christine H Andreassen, Katrine H Poulsen, Daniel El Fassi

J Bone Miner Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With -Mutant Chronic Myeloproliferative Neoplasms.
Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, Uffe Klausen, Stine Emilie Weis-Banke, Daniel El Fassi

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis.
Malene Risum, Jannik Helweg-Larsen, Søren Lykke Petersen, Peter Kampmann, Ulrik Malthe Overgaard, Daniel El Fassi

J Fungi (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen, Mads Emil Bjørn, Christen Lykkegaard Andersen, Daniel El Fassi

Haematologica· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy.
Amina Nardo-Marino, Katrine Bukan, Henrik Vedel Nielsen, Daniel El Fassi

Eur J Rheumatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis